Innovation Reimagined

At Adhera, we pride ourselves on identifying new uses for existing drugs and drug candidates, lowering risk while saving millions of dollars and years in development.

Drug R&D + Therapeutic Solutions led by world-class scientists.

We specialize in advancing drugs for large areas of unmet medical need, maximizing the gap between expense and market opportunity. Some may call it brilliant; we call it innovation reimagined.

Our Research

Solving unmet medical needs

With 2 Phase-2 drugs in accelerated pathways, 4 large addressable markets of unmet needs, Adhera seeks to outstand in the biomedical market.

Investor Relations
Drug Discovery
Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet.
Unmet Needs
From Type 1 diabetes to Parkinsons, we are trying to change millions of lives.
Accelerated Pathways
Phase 2-ready drugs with strong safety and tolerability profiles.

Real solutions for real issues

At Adhera, we pride ourselves on identifying new uses for existing drugs and drug candidates, lowering risk while saving millions of dollars and years in development.

Diabetes

With 2 Phase-2 drugs in accelerated pathways, 4 large addressable markets of unmet needs, Adhera seeks to outstand in the biomedical market.

Learn more

Parkinsons

With 2 Phase-2 drugs in accelerated pathways, 4 large addressable markets of unmet needs, Adhera seeks to outstand in the biomedical market.

Learn more
Discover our drug development research, other use cases and how it's progressing.